ARENA PHARMACEUTICALS INC (ARNA) Stock Analyst Earnings Estimates
NASDAQ:ARNA - Nasdaq - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 806.4M 4,380.00% | 300K -99.96% | 54K -82.00% | 31.031M 57,365.27% | 90.683M 192.23% | 222.263M 145.10% | 555.656M 150.00% | |
| EBITDA YoY % growth | 500.5M 454.96% | -422.8M -184.48% | -541.789M -28.14% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 497.3M 443.44% | -426.7M -185.80% | -545.661M -27.88% | N/A | N/A | N/A | N/A | |
| Operating Margin | 61.67% | -142,233.33% | -1,010,483.33% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 7.88 363.55% | -7.40 -193.91% | -8.84 -19.46% | -8.61 2.60% | -8.28 3.82% | -8.86 -6.95% | -9.66 -9.09% |
| Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -2.26 -14.04% | -2.30 4.02% | -2.40 -16.03% | -2.42 -1.21% |
| Revenue Q2Q % growth | 863.603K | 863.603K | 863.603K | 1.255M 2,223.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | -2.39 -13.81% | -2.31 | -0.08 | -3.59% |
| Q3 2021 Q2Q % growth | -2.07 -22.49% | -2.58 | 0.51 | 19.89% |
| Q2 2021 Q2Q % growth | -2.40 -49.07% | -2.24 | -0.16 | -6.94% |
| Q1 2021 Q2Q % growth | -1.98 1.00% | -2.20 | 0.22 | 10.06% |
| Q4 2020 Q2Q % growth | -2.10 -19.32% | -1.89 | -0.21 | -11.21% |
| Q3 2020 Q2Q % growth | -1.69 -15.75% | -1.91 | 0.22 | 11.49% |
| Q2 2020 Q2Q % growth | -1.61 -29.84% | -2.07 | 0.46 | 22.19% |
| Q1 2020 Q2Q % growth | -2.00 -116.21% | -2.33 | 0.33 | 14.18% |
| Q4 2019 Q2Q % growth | -1.76 | -1.58 | -0.18 | -11.54% |
| Q3 2019 Q2Q % growth | -1.46 | -1.35 | -0.11 | -8.54% |
| Q2 2019 Q2Q % growth | -1.24 | -1.10 | -0.14 | -12.30% |
| Q1 2019 Q2Q % growth | 12.34 | 14.16 | -1.82 | -12.87% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | 54K | 678.667K | -624.667K | -92.04% |
| Q3 2021 Q2Q % growth | 693.6K | -693.6K | -100.00% | |
| Q2 2021 Q2Q % growth | 826.812K | -826.812K | -100.00% | |
| Q1 2021 Q2Q % growth | -100.00% | 582.859K | -582.859K | -100.00% |
| Q4 2020 Q2Q % growth | -100.00% | 567.304K | -567.304K | -100.00% |
| Q3 2020 Q2Q % growth | -100.00% | 1.254M | -1.254M | -100.00% |
| Q2 2020 Q2Q % growth | -100.00% | 1.502M | -1.502M | -100.00% |
| Q1 2020 Q2Q % growth | 300K -99.96% | 1.612M | -1.312M | -81.38% |
| Q4 2019 Q2Q % growth | 3M | 1.778M | 1.222M | 68.74% |
| Q3 2019 Q2Q % growth | 1.4M | 2.102M | -701.649K | -33.39% |
| Q2 2019 Q2Q % growth | 1M | 2.966M | -1.966M | -66.29% |
| Q1 2019 Q2Q % growth | 801.1M | 817.735M | -16.635M | -2.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |